Deals wrap: Dealing with regulation
Email 
Print
Banks are self-regulating in advance of new financial reforms. Are recent moves by Goldman Sachs and JPMorgan “smoke and mirrors” or a way to subtly shift the form of impending regulation? *View analysis *View Q&A on Wall Street reform*Full coverage of regulatory news
“Unlocking the potential of Genzyme’s experimental multiple sclerosis drug Campath could be key to prying a higher price for the U.S. biotech from Sanofi-Aventis,” writes Lewis Krauskopf and Ben Hirschler. *View analysis *View WSJ blog
General Electric is building up its industrial business with a $3 billion bid for Dresser Inc. The deal announcement came the same day as oilfield services company Wellstream rejected GE’s takeover approach. *View article
Children’s apparel retailer Gymboree is exploring a sale of the company, sources say. Lisa Lee at Dow Jones Investment Banker takes a look at why the company is so attractive to private equity firms. *View article
Post Your Comment
-
Author Profile
-
